Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Equity Ratio (2020 - 2025)

iSpecimen has reported Equity Ratio over the past 6 years, most recently at 0.32 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.32 for Q4 2025, down 8.5% from a year ago — trailing twelve months through Dec 2025 was 0.32 (down 8.5% YoY), and the annual figure for FY2025 was 0.32, down 8.5%.
  • Equity Ratio for Q4 2025 was 0.32 at iSpecimen, down from 0.34 in the prior quarter.
  • Over the last five years, Equity Ratio for ISPC hit a ceiling of 0.84 in Q2 2023 and a floor of 0.1 in Q2 2025.
  • Median Equity Ratio over the past 5 years was 0.62 (2023), compared with a mean of 0.59.
  • Biggest five-year swings in Equity Ratio: skyrocketed 118.99% in 2021 and later plummeted 79.85% in 2025.
  • iSpecimen's Equity Ratio stood at 0.83 in 2021, then decreased by 1.09% to 0.82 in 2022, then dropped by 25.36% to 0.62 in 2023, then crashed by 42.49% to 0.35 in 2024, then decreased by 8.5% to 0.32 in 2025.
  • The last three reported values for Equity Ratio were 0.32 (Q4 2025), 0.34 (Q3 2025), and 0.1 (Q2 2025) per Business Quant data.